Drugs / norethandrolone
norethandrolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00700544 | Jun 2002 → Apr 2005 | acute myeloid leukemia | University Hospital, Grenoble | Completed | Met primary |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | norethandrolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00700544 ↗ |
| Known as | Nilevar | ChEMBL registry synonym — accepted as the source's own label CHEMBL1697845 ↗ |
| Known as | Noretandrolona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1697845 ↗ |
| Known as | norethandrolone = nilevar | “norethandrolone = nilevar®” NCT00700544 ↗ |
| Known as | NSC-70581 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1697845 ↗ |
| Known as | Pronabol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1697845 ↗ |
| Known as | Solevar | ChEMBL registry synonym — accepted as the source's own label CHEMBL1697845 ↗ |
| Modality | Small molecule | — CHEMBL1697845 ↗ |